Hydrazono-malonitriles

Details for Australian Patent Application No. 2002363368 (hide)

Owner Merck Patent GmbH

Inventors Ehring, Thomas; Beier, Norbert; Wolf, Michael; Schelling, Pierre; Eggenweiler, Hans-Michael

Agent Davies Collison Cave

Pub. Number AU-B-2002363368

PCT Number PCT/EP02/11351

PCT Pub. Number WO2003/039548

Priority 01125455.4 05.11.01 EP

Filing date 10 October 2002

Wipo publication date 19 May 2003

Acceptance publication date 13 December 2007

International Classifications

A61K 31/50 (2006.01) - Pyridazines

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 45/08 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/16 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07D 237/04 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

19 June 2003 Complete Application Filed

  Priority application(s): 01125455.4 05.11.01 EP

24 July 2003 Application Open to Public Inspection

  Published as AU-B-2002363368

13 December 2007 Application Accepted

  Published as AU-B-2002363368

10 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002363369-Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage

2002363367-USE OF ENDOTHELIN RECEPTOR ANTAGONISTS IN THE TREATMENT OF TUMOUR DISEASES